Natasha J. Caplen

Dr. Natasha J. Caplen

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Cancer Cell
Verified
Journal Article
Closed access
NYNozomu Yanaihara
Nozomu Yanaihara
NCNatasha J. Caplen
Natasha J. Caplen
EBElise Bowman
Elise Bowman
MSMasahiro Seike
Masahiro Seike
KKKensuke Kumamoto
Kensuke Kumamoto
CHCurtis C. Harris
Curtis C. Harris

31 July 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NCNatasha J. Caplen
Natasha J. Caplen
SPSusan Parrish
Susan Parrish
FIFarhad Imani
Farhad Imani
AFAndrew Fire
Andrew Fire
RMRichard A. Morgan
Richard A. Morgan
Short interfering RNAs (siRNAs) are double-stranded RNAs of ≈21–25 nucleotides that have been shown to function as key intermediaries in triggering sequence-specific RNA degradation during posttranscriptional gene silencing in plants and RNA interference in invertebrates. siRNAs have a characteristic structure, with 5′-phosphate/3′-hydroxyl ends and a 2-base 3′ overhang on each strand of the duplex. In this study, we present data that synthetic siRNAs can induce gene-specific inhibition of expression in Caenorhabditis elegans and in cell lines from humans and mice. In each case, the interference by siRNAs was superior to the inhibition of gene expression mediated by single-stranded antisense oligonucleotides. The siRNAs seem to avoid the well documented nonspecific effects triggered by longer double-stranded RNAs in mammalian cells. These observations may open a path toward the use of siRNAs as a reverse genetic and therapeutic tool in mammalian cells.

1 January 1995 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
NCNatasha J. Caplen
Natasha J. Caplen
EAEric W.F.W. Alton
Eric W.F.W. Alton
PMPeter G. Mddleton
Peter G. Mddleton
JDJulia R. Dorin
Julia R. Dorin
BSBarbara J. Stevenson
Barbara J. Stevenson
DGDuncan M. Geddes
Duncan M. Geddes

9 February 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PSPeter C. Scacheri
Peter C. Scacheri
OROrit Rozenblatt-Rosen
Orit Rozenblatt-Rosen
NCNatasha J. Caplen
Natasha J. Caplen
TWTyra G. Wolfsberg
Tyra G. Wolfsberg
LULowell Umayam
Lowell Umayam
FCFrancis S. Collins
Francis S. Collins
RNA interference (RNAi) mediated by short interfering RNAs (siRNAs) is a widely used method to analyze gene function. To use RNAi knockdown accurately to infer gene function, it is essential to determine the specificity of siRNA-mediated RNAi. We have assessed the specificity of 10 different siRNAs corresponding to the MEN1 gene by examining the expression of two additional genes, TP53 (p53) and CDKN1A (p21), which are considered functionally unrelated to menin but are sensitive markers of cell state. MEN1 RNA and corresponding protein levels were all reduced after siRNA transfection of HeLa cells, although the degree of inhibition mediated by individual siRNAs varied. Unexpectedly, we observed dramatic and significant changes in protein levels of p53 and p21 that were unrelated to silencing of the target gene. The modulations in p53 and p21 levels were not abolished on titration of the siRNAs, and similar results were obtained in three other cell lines; in none of the cell lines tested did we see an effect on the protein levels of actin. These data suggest that siRNAs can induce nonspecific effects on protein levels that are siRNA sequence dependent but that these effects may be difficult to detect until genes central to a pivotal cellular response, such as p53 and p21, are studied. We find no evidence that activation of the double-stranded RNA-triggered IFN-associated antiviral pathways accounts for these effects, but we speculate that partial complementary sequence matches to off-target genes may result in a micro-RNA-like inhibition of translation.

1 October 1993 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EAE. W. F. W. Alton
E. W. F. W. Alton
PMP. G. Middleton
P. G. Middleton
NCNatasha J. Caplen
Natasha J. Caplen
SSS. N. Smith
S. N. Smith
DSD. M. Steel
D. M. Steel
DPD. J. Porteous
D. J. Porteous

1 July 2000 in Gene
Verified
Journal Article
Closed access
NCNatasha J. Caplen
Natasha J. Caplen
JFJamie Fleenor
Jamie Fleenor
AFAndrew Fire
Andrew Fire
RMRichard A. Morgan
Richard A. Morgan